Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Return On Total Capital

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.

The item "Return-On-Total-Capital" stands at 0.2809 percent as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Return On Total Capital" stands at 0.2809 Percent. This represents a decrease of -0.92 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.14 percentage points compared to the value the year prior.
The 1 year change in percentage points is -2.14.
The 3 year change in percentage points is -1.58.

The Serie's long term average value is 1.74 percent. It's latest available value, on 09/30/2025, is 1.46 percentage points lower, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0.
The Serie's change in percentage points from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -2.66.

Return On Total Capital for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Return On Total Capital905,699,262,464.00
LogoJohnson & Johnson - Return On Total Capital486,508,953,600.00
LogoAbbVie Inc - Return On Total Capital399,570,305,024.00
LogoRoche Holding AG - Return On Total Capital317,433,206,677.55
LogoAstraZeneca PLC - Return On Total Capital280,205,508,085.11